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BACKGROUND AND AIMS
Arterial pulse pressure (PP) reflects arterial stiffness 
and is considered as an independent cardiovascular 
risk factor. However, studies regarding PP in type 1 
diabetic patients are scarce. The aim of the study was 
to investigate the influence of the duration of type 1 
METHODS
• 159 diabetic patients (20-60 years) were evaluated 
with a continuous noninvasive arterial blood 
pressure monitoring (Finapres®). Recordings were 
performed in standing position (1 min), in squatting 
position (1 min), and again in standing position (1 
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POPULATION
diabetes on PP, as well as to correlate PP with the 
quality of blood glucose control, the presence of 
microalbuminuria (µA) and/or the use of drugs blocking 
the renin-angiotensin system.
m n . resen e  a a correspon  o average 
(systolic minus diastolic arterial pressure) values 
calculated during the overall recording in the 3 
positions.
• Blood glucose control was assessed by concomitant 
HbA1c levels
• Microalbuminuria (μA) was measured as a marker 
of early diabetic nephropathy.RESULTS    
No significant differences were observed in diabetic patients receiving (56 ± 14 
mm Hg) or not receiving (54 ± 15 mm Hg) an ACE inhibitor or an ARB.
Diabetic patients with µA (57 ± 17 mm Hg) and without µA (54 ± 14 mm Hg) 
have almost similar PP values (NS). 
µA levels
<30mg (n=101)




PP was higher in men than in women, in diabetic (58 15 vs 50 14 mm Hg; p 
< 0.001) and non-diabetic (55 14 vs 47 12 mm Hg; p < 0.001) subjects






















































• PP increased progressively throughout the 4 subgroups according to diabetes 
duration (47 ± 16 vs 51 ± 13 vs 59 ± 14 vs 62 ± 12 mm Hg, respectively; p < 
0.001) : see subgroup repartition on the left (*).
• There was a marked difference between groups 1-2 and groups 3-4 (49 ± 14 
vs 59 ± 14 mm Hg; p < 0.00002) in diabetic patients, but not in non-diabetic 
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35 years for groups 1-2 vs 46 years for groups 3-4).
• Percentage of subjects with PP > 60 mm Hg (considered as a risk factor) was 
similar in diabetic and non-diabetic individuals in groups 1-2 (27 vs 25 %, NS); 
however, in groups 3-4, the prevalence of subjects with PP > 60 mm Hg was 
significantly higher in diabetic patients than in controls (44 vs 27 %, p < 0.05).
• The difference in PP between the four groups of diabetic patients, already 
present in standing position, was amplified in squatting position.
*In order to differentiate the effects of 
duration of diabetes from the effect of 
increasing age, healthy subjects were 
used as controls and matched for age, 
sex and body mass index (n = 30 in
 -   
21-30  (n=57)




Type 1 diabetes was associated with a progressive increase in PP according to the duration of the disease, in an age 
range where no significant influence of age was observed in a non-diabetic population. PP was not significantly 
influenced by concomitant HbA1c levels, a reflect of recent blood glucose control. The presence of microalbuminuria or 
the blockade of the renin-angiotensin system do not influence PP levels in the studied population. 
         
each subgroup).
